239 related articles for article (PubMed ID: 1550533)
1. Treatment of motion sickness in parabolic flight with buccal scopolamine.
Norfleet WT; Degioanni JJ; Calkins DS; Reschke MF; Bungo MW; Kutyna FA; Homick JL
Aviat Space Environ Med; 1992 Jan; 63(1):46-51. PubMed ID: 1550533
[TBL] [Abstract][Full Text] [Related]
2. Relative bioavailability of scopolamine dosage forms and interaction with dextroamphetamine.
Boyd JL; Du B; Vaksman Z; Locke JP; Putcha L
J Gravit Physiol; 2007 Jul; 14(1):P107-8. PubMed ID: 18372722
[TBL] [Abstract][Full Text] [Related]
3. Treatment of severe motion sickness with antimotion sickness drug injections.
Graybiel A; Lackner JR
Aviat Space Environ Med; 1987 Aug; 58(8):773-6. PubMed ID: 3632537
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness.
Wood CD; Stewart JJ; Wood MJ; Manno JE; Manno BR; Mims ME
Aviat Space Environ Med; 1990 Feb; 61(2):157-61. PubMed ID: 2178599
[TBL] [Abstract][Full Text] [Related]
5. Elicitation of motion sickness by head movements in the microgravity phase of parabolic flight maneuvers.
Lackner JR; Graybiel A
Aviat Space Environ Med; 1984 Jun; 55(6):513-20. PubMed ID: 6466247
[TBL] [Abstract][Full Text] [Related]
6. Effect of transdermally administered scopolamine in preventing motion sickness.
McCauley ME; Royal JW; Shaw JE; Schmitt LG
Aviat Space Environ Med; 1979 Nov; 50(11):1108-11. PubMed ID: 393242
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, Predictors, and Prevention of Motion Sickness in Zero-G Parabolic Flights.
Golding JF; Paillard AC; Normand H; Besnard S; Denise P
Aerosp Med Hum Perform; 2017 Jan; 88(1):3-9. PubMed ID: 28061915
[TBL] [Abstract][Full Text] [Related]
8. Motion sickness in cats: a symptom rating scale used in laboratory and flight tests.
Suri KB; Crampton GH; Daunton NG
Aviat Space Environ Med; 1979 Jun; 50(6):614-8. PubMed ID: 475712
[TBL] [Abstract][Full Text] [Related]
9. Scopolamine alone or combined with ephedrine in seasickness: a double-blind, placebo-controlled study.
Laitinen LA; Tokola O; Gothoni G; Vapaatalo H
Aviat Space Environ Med; 1981 Jan; 52(1):6-10. PubMed ID: 7011299
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of antimotion sickness drugs.
Wood CD; Manno JE; Wood MJ; Manno BR; Redetzki HM
Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
[TBL] [Abstract][Full Text] [Related]
11. Sudden emesis following parabolic flight maneuvers: implications for space motion sickness.
Lackner JR; Graybiel A
Aviat Space Environ Med; 1986 Apr; 57(4):343-7. PubMed ID: 3485969
[TBL] [Abstract][Full Text] [Related]
12. Transderm scopolamine for the control of perioperative nausea.
Stromberg BV; Reines DH; Ackerly J
Am Surg; 1991 Nov; 57(11):712-5. PubMed ID: 1746779
[TBL] [Abstract][Full Text] [Related]
13. Treatment efficacy of intramuscular promethazine for space motion sickness.
Davis JR; Jennings RT; Beck BG; Bagian JP
Aviat Space Environ Med; 1993 Mar; 64(3 Pt 1):230-3. PubMed ID: 8447805
[TBL] [Abstract][Full Text] [Related]
14. Comparison of treatment strategies for Space Motion Sickness.
Davis JR; Jennings RT; Beck BG
Microgravity Q; 1992 Jul; 2(3):173-7. PubMed ID: 11541442
[TBL] [Abstract][Full Text] [Related]
15. The effect of antimotion sickness drugs on habituation to motion.
Wood CD; Manno JE; Manno BR; Odenheimer RC; Bairnsfather LE
Aviat Space Environ Med; 1986 Jun; 57(6):539-42. PubMed ID: 3718377
[TBL] [Abstract][Full Text] [Related]
16. Prevention of experimental motion sickness by scopolamine absorbed through the skin.
Graybiel A; Knepton J; Shaw J
Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234
[TBL] [Abstract][Full Text] [Related]
17. Drug treatment of motion sickness: scopolamine alone and combined with ephedrine in real and simulated situations.
Tokola O; Laitinen LA; Aho J; Gothoni G; Vapaatalo H
Aviat Space Environ Med; 1984 Jul; 55(7):636-41. PubMed ID: 6466260
[TBL] [Abstract][Full Text] [Related]
18. Experimental motion sickness: efficacy of transdermal scopolamine plus ephedrine.
Graybiel A; Cramer DB; Wood CD
Aviat Space Environ Med; 1981 Jun; 52(6):337-9. PubMed ID: 7259691
[TBL] [Abstract][Full Text] [Related]
19. Prediction of space motion sickness susceptibility by disconjugate eye torsion in parabolic flight.
Diamond SG; Markham CH
Aviat Space Environ Med; 1991 Mar; 62(3):201-5. PubMed ID: 2012564
[TBL] [Abstract][Full Text] [Related]
20. The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus.
Pyykkö I; Padoan S; Schalén L; Lyttkens L; Magnusson M; Henriksson NG
Aviat Space Environ Med; 1985 Aug; 56(8):777-82. PubMed ID: 3929760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
